Worldwide developer, manufacturer and marketer of medical devices selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, February 4, 2008 – clinivation, Inc. announced today that Boston Scientific Corporation (NYSE: BSX) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“Boston Scientific is a worldwide leader in the advancement of less-invasive medicine, complete with an extensive portfolio of innovative products, technologies and services. We are delighted they have selected clinivation WorldView as their source for regulatory intelligence,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
“With information on >99% of world markets, BSC’s regulatory management will stay up-to-date with ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Boston Scientific Corporation
The Boston Scientific Corporation (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 29,000 employees and revenue of $7.8 billion in 2006. For more than 25 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company’s products help physicians and other medical professionals improve their patients’ quality of life by providing alternatives to surgery.